Riber (ALRIB) H1 2025 earnings summary

Executive summary

• First-half 2025 revenues reached €10.7m, with earnings impacted by pronounced seasonality and a delivery schedule weighted to the second half.

• Order book at June 30, 2025, stood at €27.7m, later strengthened by €14m in additional orders after the summer.

• First two sales of ROSIE, a key silicon photonics product, mark a milestone in the technology roadmap.

Financial highlights

• Revenues for H1 2025 were €10.7m, down from €13.7m in H1 2024.

• Gross margin improved to 36.2% of revenues, up from 34.8% in H1 2024.

• Operating income was €(0.7)m, compared to break-even in H1 2024.

• Net income was €(0.8)m, versus a profit of €0.2m in H1 2024, including €0.1m in net financial expenses.

Outlook and guidance

• Target for 2025 confirmed: revenues above €40m.

• Expects new orders in Q4 2025, driven by investment in AI and quantum technologies.

• ROSIE ramp-up validated by initial sales and growing market interest.